In our study, higher levels of PD1+CD8+ T cells were detected during T-DXd treatment, which have been reported to be associated with a repertoire of clonally expanded tumor-reactive cells and the favorable efficacy of PD-1 inhibitors (36, 40, 41). This evidence concerns the gene CD8A and neoplasm.